1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost

A merger and a $150 million capital infusion is giving Werewolf's next chapter more firepower, but investors still face risks ...

Why Werewolf Therapeutics stock exploded higher and what comes next

Werewolf Therapeutics (HOWL) stock exploded higher on Friday morning after management said the company has agreed to a ...

Werewolf Therapeutics (HOWL) stock is trending overnight—here's why it jumped 90% after hours

Werewolf Therapeutics Inc. HOWL shares are trending on Friday. Shares of the Massachusetts-based clinical-stage ...

Werewolf Therapeutics to Merge With Ambros Therapeutics in All-Stock Deal

Werewolf Therapeutics (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome ...

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...